Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know

Key Takeaways Lilly stock surged 16% last week amid optimism following Pfizer's federal agreement announcement.The Pfizer deal eased investor concerns over drug pricing and tariffs in the pharma sector.Lilly's $27B U.S. expansion aims to boost production of Mounjaro and Zepbound medicines.Shares of Eli Lilly (LLY) have surged 16% in the past week, driven primarily by positive investor expectations around the broader pharmaceutical sector after Pfizer (PFE) announced a landmark agreement with the Trump admin ...